About
Treatments for aesthetic and functional eyelid conditions
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
133
By Phase
PHASE1/PHASE2: 1PHASE4: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05715346Lead Sponsor
LEV102 Topical Gel in Acquired Blepharoptosis
PHASE1/PHASE2Completed
33 participants
Started: Feb 23, 2023 · Completed: Jun 24, 2023
NCT01008345Collaborator
Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol
PHASE4Completed
100 participants
Started: Sep 30, 2008 · Completed: Jun 30, 2009
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...